Trupanion, Inc. (TRUP)

For informational purposes only. Not financial advice.

Trupanion, Inc. (TRUP) is a publicly traded company trading at $27.16 with a market cap of $1.18B. It holds a cautious AI score of 45/100 based on fundamental, technical, and sentiment analysis.

Trupanion, Inc. is a leading provider of pet medical insurance, operating on a monthly subscription basis. The company focuses on cats and dogs across the United States, Canada, Puerto Rico, and Australia.

46/100 AI Score MCap $1.18B Vol 316.1K

Company Overview

CEOMargaret Rosemary Maria Tooth
Employees1130
HeadquartersSeattle, WA, US
IPO Year2014

Trupanion is a pioneer in subscription-based pet medical insurance, offering a unique value proposition to pet owners and veterinarians across North America and Australia. With a focus on direct payments to veterinary hospitals, Trupanion is transforming pet healthcare financing and experiencing rapid growth in a burgeoning market.

Investment Thesis

Trupanion presents a compelling investment opportunity due to its strong market position in the rapidly growing pet insurance industry. The company's subscription-based model provides recurring revenue and high customer retention rates. With a P/E ratio of 92.43 and a profit margin of 1.1%, there is significant potential for margin expansion as the company scales its operations. Key growth catalysts include increasing pet ownership, rising veterinary costs, and growing awareness of pet insurance. Trupanion's focus on direct payments to veterinary hospitals streamlines the claims process and enhances customer satisfaction. Investors should consider Trupanion for its long-term growth potential and its ability to capitalize on the increasing demand for pet healthcare solutions. The company's beta of 1.60 suggests higher volatility compared to the market.

Key Highlights

  • Market Cap of $1.43B reflects investor confidence in Trupanion's growth potential within the pet insurance market.
  • P/E Ratio of 92.43 indicates a premium valuation, suggesting high expectations for future earnings growth.
  • Gross Margin of 15.6% demonstrates the company's ability to generate revenue after accounting for the cost of insurance claims.
  • Profit Margin of 1.1% signifies an opportunity for improvement through operational efficiencies and increased scale.
  • Beta of 1.60 suggests that the stock is more volatile than the market, potentially offering higher returns but also greater risk.

Competitors

Strengths

  • Subscription-based revenue model provides recurring income.
  • Direct payment system to veterinary hospitals streamlines claims.
  • Established brand reputation in the pet insurance market.
  • Proprietary data and analytics capabilities for risk assessment.

Weaknesses

  • Relatively low profit margin of 1.1%.
  • High P/E ratio of 92.43 indicates premium valuation.
  • Limited geographic presence compared to larger insurance companies.
  • Dependence on veterinarian relationships for customer acquisition.

Catalysts

  • Ongoing: Increasing pet ownership and rising veterinary costs driving demand for pet insurance.
  • Ongoing: Growing awareness of pet insurance among pet owners.
  • Upcoming: Potential partnerships with major veterinary hospital chains.
  • Upcoming: Launch of new insurance products and services tailored to specific pet needs.
  • Ongoing: Expansion into new geographic markets, including international regions.

Risks

  • Potential: Increasing competition from established insurance companies with greater resources.
  • Potential: Changes in regulations governing pet insurance could impact profitability.
  • Potential: Economic downturn impacting pet owner spending on non-essential services.
  • Ongoing: Negative publicity related to claims processing or customer service could damage brand reputation.
  • Ongoing: High beta of 1.60 indicates higher volatility compared to the market.

Growth Opportunities

  • Expansion into New Geographic Markets: Trupanion has the opportunity to expand its operations into new geographic markets, both domestically and internationally. The global pet insurance market is estimated to reach $10 billion by 2027, presenting a significant growth opportunity for Trupanion. Expanding into new markets will require careful consideration of local regulations and cultural differences, but the potential rewards are substantial. This expansion could begin within the next 2-3 years.
  • Increased Penetration in Existing Markets: Trupanion can increase its market share in existing markets by targeting specific customer segments and offering tailored insurance plans. The company can leverage its data analytics capabilities to identify underserved markets and develop targeted marketing campaigns. Increasing penetration in existing markets will require a focus on customer acquisition and retention, but the potential for growth is significant. This is an ongoing effort with continuous refinement.
  • Development of New Products and Services: Trupanion can develop new products and services to complement its existing insurance offerings. This could include wellness plans, telemedicine services, and other value-added services that appeal to pet owners. Developing new products and services will require a focus on innovation and customer needs, but the potential for growth is significant. These offerings could be introduced within the next 1-2 years.
  • Strategic Partnerships with Veterinary Hospitals: Trupanion can strengthen its relationships with veterinary hospitals by forming strategic partnerships. This could involve offering exclusive discounts to Trupanion members or co-branding marketing materials. Strengthening relationships with veterinary hospitals will require a focus on mutual benefit and collaboration, but the potential for growth is significant. These partnerships are an ongoing effort.
  • Leveraging Technology to Improve Efficiency: Trupanion can leverage technology to improve its operational efficiency and enhance the customer experience. This could include automating claims processing, developing a mobile app for pet owners, and using artificial intelligence to personalize insurance plans. Leveraging technology will require a focus on innovation and investment, but the potential for cost savings and customer satisfaction is significant. This is an ongoing process with continuous updates.

Opportunities

  • Expansion into new geographic markets.
  • Increased penetration in existing markets.
  • Development of new products and services.
  • Strategic partnerships with veterinary hospitals.

Threats

  • Increasing competition from established insurance companies.
  • Changes in regulations governing pet insurance.
  • Economic downturn impacting pet owner spending.
  • Negative publicity related to claims processing or customer service.

Competitive Advantages

  • Subscription-based revenue model provides recurring income.
  • Direct payment system to veterinary hospitals streamlines claims.
  • Established brand reputation in the pet insurance market.
  • Proprietary data and analytics capabilities for risk assessment.

About

Founded in 2000 and headquartered in Seattle, Washington, Trupanion, Inc. has emerged as a key player in the pet insurance industry. Originally named Vetinsurance International, Inc., the company rebranded as Trupanion, Inc. in 2013, marking a pivotal moment in its evolution. Trupanion provides comprehensive medical insurance for cats and dogs, operating primarily on a monthly subscription model. This subscription-based approach offers predictable revenue streams and fosters long-term customer relationships. The company operates through two distinct segments: Subscription Business and Other Business. The Subscription Business segment focuses on direct-to-consumer and veterinarian-referred insurance plans. The Other Business segment includes other products and services offered by Trupanion. Trupanion's geographic reach extends across the United States, Canada, Puerto Rico, and Australia, demonstrating its expanding global footprint. The company's core mission is to help pet owners afford the best veterinary care possible, fostering a strong bond between pets and their families. Trupanion differentiates itself by focusing on simplicity and transparency in its insurance policies, aiming to reduce the financial burden associated with unexpected veterinary expenses.

What They Do

  • Provide medical insurance for cats and dogs.
  • Operate on a monthly subscription basis.
  • Serve pet owners and veterinarians.
  • Offer insurance plans in the United States, Canada, Puerto Rico, and Australia.
  • Process claims for veterinary medical expenses.
  • Focus on direct payments to veterinary hospitals.

Business Model

  • Generate revenue through monthly subscription fees.
  • Underwrite pet medical insurance policies.
  • Manage risk and claims related to pet healthcare.
  • Partner with veterinarians to provide care and process payments.

Industry Context

The pet insurance industry is experiencing significant growth, driven by increasing pet ownership and rising veterinary costs. The market is becoming more competitive, with several players vying for market share. Trupanion differentiates itself through its subscription-based model and focus on direct payments to veterinary hospitals. The industry is expected to continue to grow at a rapid pace, fueled by increasing awareness of pet insurance and the desire of pet owners to provide the best possible care for their animals. Trupanion is well-positioned to capitalize on this growth, given its established brand and strong relationships with veterinarians.

Key Customers

  • Pet owners seeking financial protection for veterinary expenses.
  • Veterinarians looking for efficient payment processing.
  • Animal shelters and rescue organizations.
  • Breeders and pet professionals.
AI Confidence: 73% Updated: 2/8/2026

Financials

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q4 2024 $337M $2M $0.04
Q1 2025 $342M -$1M $-0.03
Q2 2025 $354M $9M $0.22
Q3 2025 $367M $6M $0.13

Source: Company filings

Chart & Info

Price Chart

Trupanion, Inc. (TRUP) stock price: $27.16 (+0.00, +0.00%)

Why Bull

  • Trupanion's subscription model is a real winner, locking in recurring revenue like clockwork. Think of it as the Netflix of pet insurance – sticky and reliable.
  • Recent rumblings suggest big players might be eyeing Trupanion. Acquisition buzz can light a fire under a stock, even if it's just speculation.
  • The pet care industry is booming, and Trupanion is riding that wave. People are spending serious cash on their furry friends, and insurance is part of that.
  • The community is buzzing about Trupanion's brand loyalty. Happy customers stick around, and that translates to long-term value.

Why Bear

  • Competition is heating up in the pet insurance space. New players are entering the game, and they're hungry for market share.
  • Insider activity has been a bit shaky lately. Some folks are selling shares, and that can make investors nervous.
  • Community sentiment is showing some cracks. A few users are complaining about rising premiums and claim denials.
  • Market perception is starting to shift. Some analysts are questioning Trupanion's growth potential, especially as interest rates rise.

Latest News

Technical Analysis

bearish Trend
RSI(14)
22.0
MACD
--
Volume
NaN

Rationale

AI-generated technical analysis for TRUP including trend direction, momentum, and pattern recognition.

What to Watch

Key support and resistance levels, volume signals, and upcoming events.

Risk Management

Position sizing, stop-loss levels, and risk-reward assessment.

Community

Discussion

Share your analysis and discuss Trupanion, Inc. (TRUP) with other investors. Log in to post.

Sentiment

Community sentiment and discussion activity for TRUP.

Make a Prediction

Set your price target for Trupanion, Inc. (TRUP), choose a timeframe, and track your prediction accuracy.

Current price: $27.16

Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for TRUP.

Price Targets

Low
$35.00
Consensus
$40.67
High
$45.00

Median: $42.00 (+49.7% from current price)

Insider Flow (30d)

Tooth Margaret
Insider
1 week ago
BOUGHT
338,175 shares
MCGIBNEY BRENNA
Insider
1 week ago
BOUGHT
44,922 shares
RAWLINGS DARRYL
Insider
1 week ago
BOUGHT
42,232 shares
Qureshi Fawwad
Insider
1 week ago
BOUGHT
30,000 shares
WHEELER SIMON
Insider
1 week ago
BOUGHT
25,167 shares
BEARMAN ASHER
Insider
1 week ago
BOUGHT
141,747 shares
GALLAGHER JOHN R
Insider
1 week ago
BOUGHT
153,296 shares
DREYER EMILY
Insider
1 week ago
BOUGHT
89,079 shares
WEINRAUCH STEVE
Insider
1 week ago
BOUGHT
219,615 shares
WEINRAUCH STEVE
Insider
1 week ago
SOLD
72,559 shares
$1.9M
MCGIBNEY BRENNA
Insider
1 week ago
BOUGHT
42,027 shares
WEINRAUCH STEVE
Insider
1 week ago
BOUGHT
155,483 shares
Qureshi Fawwad
Insider
1 week ago
BOUGHT
35,031 shares
BEARMAN ASHER
Insider
1 week ago
BOUGHT
284,249 shares
DREYER EMILY
Insider
1 week ago
BOUGHT
89,556 shares
WHEELER SIMON
Insider
1 week ago
BOUGHT
78,393 shares
RUBIN HOWARD E
Insider
1 week ago
BOUGHT
697,650 shares
Tooth Margaret
Insider
1 week ago
BOUGHT
693,756 shares
RAWLINGS DARRYL
Insider
1 week ago
BOUGHT
78,822 shares
GALLAGHER JOHN R
Insider
1 week ago
BOUGHT
129,438 shares

MoonshotScore

46/100

Score Factors

  • Revenue Growth 4/100

    Revenue grew only 11.9% YoY, suggesting the company is in a slower growth phase.

  • Gross Margin 3/100

    Gross margin of 19.5% is below average, suggesting thin margins and potential pricing pressure.

  • Operating Leverage 4/100

    Limited operating leverage due to slower revenue growth, keeping profit scaling constrained.

  • Cash Runway 8/100

    Strong cash reserves of $138M provide a solid financial cushion for growth investments and market downturns.

  • R&D Intensity 2/100

    R&D at only 2.6% of revenue suggests limited innovation investment, which may impact long-term competitiveness.

  • Insider Activity 6/100

    No significant insider buying or selling recently, which is neutral for the stock outlook.

  • Short Interest 10/100

    Daily turnover of 1.80% indicates healthy liquidity with smooth entry/exit for investors.

  • Price Momentum 2/100

    No bullish technical signals detected. The stock lacks upward price momentum currently.

  • News Sentiment 5/100

    No sentiment data available

What does this score mean?

The MoonshotScore rates TRUP's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.

Frequently Asked Questions

What does Trupanion, Inc. do?

Trupanion, Inc. is a pet insurance company that provides medical insurance for cats and dogs on a monthly subscription basis. The company operates in the United States, Canada, Puerto Rico, and Australia, serving pet owners and veterinarians. Trupanion's core business revolves around offering comprehensive insurance plans that cover a significant portion of veterinary medical expenses. Its unique selling proposition includes direct payments to veterinary hospitals, streamlining the claims process and reducing the financial burden on pet owners. This approach fosters strong relationships with veterinarians and enhances customer satisfaction, positioning Trupanion as a leader in the pet insurance market.

Is TRUP stock a good buy?

TRUP stock presents a mixed investment profile. The company operates in a high-growth industry with increasing pet ownership and rising veterinary costs driving demand. Trupanion's subscription-based model provides recurring revenue and a degree of predictability. However, the company's high P/E ratio of 92.43 suggests a premium valuation, indicating that investors have high expectations for future growth. The relatively low profit margin of 1.1% also raises concerns about profitability. Investors should carefully consider the company's growth potential, competitive landscape, and valuation before making a decision. The stock's beta of 1.60 indicates higher volatility compared to the market.

What are the main risks for TRUP?

Trupanion faces several risks, including increasing competition from established insurance companies with greater resources. These larger companies could potentially offer more competitive pricing or broader coverage options. Changes in regulations governing pet insurance could also impact Trupanion's profitability. An economic downturn could reduce pet owner spending on non-essential services like pet insurance. Negative publicity related to claims processing or customer service could damage the company's brand reputation and lead to customer attrition. Additionally, the company's high beta of 1.60 indicates higher volatility compared to the market, making it more susceptible to market fluctuations.

Is TRUP a good stock to buy?

Whether TRUP is a suitable investment depends on your goals, risk tolerance, and time horizon. Evaluate Trupanion, Inc.'s revenue growth, profit margins, debt levels, and valuation relative to peers. This is not financial advice.

What is the TRUP MoonshotScore?

The MoonshotScore rates TRUP from 0 to 100 across growth potential, financial health, market momentum, and risk factors. Scores above 70 suggest strong potential, 50-70 moderate, and below 50 warrants caution. It is recalculated daily using the latest market data. This score is informational only.

How often is TRUP data updated?

TRUP prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.

What do analysts say about TRUP?

Analyst coverage for TRUP includes consensus ratings (buy, hold, sell), 12-month price targets, and earnings estimates from major research firms. Key data points: consensus target price, number of covering analysts, recent upgrades or downgrades, and earnings beat/miss history. See the Analyst Consensus section on this page.

What are the risks of investing in TRUP?

Risk categories for TRUP include market risk, company-specific risk (management, competition), financial risk (debt, cash burn), and macroeconomic risk (rates, inflation). Beta above 1.0 indicates higher volatility than the S&P 500. Review the Risk Factors section on this page for details. All investments carry risk of loss.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Data provided for informational purposes only.

AI Analysis Notes
  • Financial data is based on the most recent available information.
  • Future performance is subject to market conditions and company-specific factors.
Data Sources
profilefundamentalsexistingCopy